Loading...
Loading...
India's raltegravir imports from CHINA total $366 across 2 shipments from 2 foreign suppliers. AUROVITAS PHARMA(TAIZHOU) CO,.LTD. leads with $325 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include AUROBINDO PHARMA LTD. This corridor reflects India's pharmaceutical import demand for raltegravir — a concentrated sourcing relationship with select suppliers from CHINA.

AUROVITAS PHARMA(TAIZHOU) CO,.LTD. is the leading Raltegravir supplier from CHINA to India, with import value of $325 across 1 shipments. The top 5 suppliers — AUROVITAS PHARMA(TAIZHOU) CO,.LTD., M/S WUXI YUEYUAN TECHNOLOGY CO — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AUROVITAS PHARMA(TAIZHOU) CO,.LTD. | $325 | 1 | 88.8% |
| 2 | M/S WUXI YUEYUAN TECHNOLOGY CO | $41 | 1 | 11.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD | $366 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Raltegravir suppliers from CHINA to India include AUROVITAS PHARMA(TAIZHOU) CO,.LTD., M/S WUXI YUEYUAN TECHNOLOGY CO. The leading supplier is AUROVITAS PHARMA(TAIZHOU) CO,.LTD. with import value of $325 USD across 1 shipments. India imported Raltegravir worth $366 USD from CHINA in total across 2 shipments.
India imported Raltegravir worth $366 USD from CHINA across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Raltegravir sourced from CHINA include AUROBINDO PHARMA LTD. The largest buyer is AUROBINDO PHARMA LTD with $366 in imports across 2 shipments.
The total value of Raltegravir imports from CHINA to India is $366 USD, across 2 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
2 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists